Association of CYP1A1*2 polymorphisms with breast cancer risk: a case control study.

Simple item page
dc.contributor.authorSurekha, Den_US
dc.contributor.authorSailaja, Ken_US
dc.contributor.authorRao, D Nageswaraen_US
dc.contributor.authorPadma, Ten_US
dc.contributor.authorRaghunadharao, Den_US
dc.contributor.authorVishnupriya, Sen_US
dc.date.accessioned2009-01-07en_US
dc.date.accessioned2009-05-29T05:02:27Z
dc.date.available2009-01-07en_US
dc.date.available2009-05-29T05:02:27Z
dc.date.issued2009-01-07en_US
dc.description.abstractBACKGROUND: The Cytochrome P-4501A1 (CYP1A1) gene, located on chromosome 15q, is involved in the metabolism of carcinogens mainly polycyclic aromatic hydrocarbons as well as estrogen. It is considered as candidate gene for low-penetrance breast cancer susceptibility. Hence the present study aims to discuss the role of CYP1A1 polymorphisms in breast cancer. MATERIALS AND METHODS: A total of 250 breast cancer patients and the same number of healthy age-matched controls were analyzed for the polymorphism of CYP1A1*2 by polymerase chain reaction-restriction fragment length polymorphism. RESULTS: In the present study, association of CYP1A1*2 (Ile 462Val) polymorphism with breast cancer was studied. Only one breast cancer patient was observed to be homozygous for Val allele but none among controls. The frequency of heterozygous Ile/Val genotype was found to be increased significantly in breast cancer patients (68.1%) as compared to controls (51.0%). Higher frequency of heterozygotes for Val allele was observed among premenopausal breast cancer patients and patients with high BMI, positive for HER2/neu status and advanced stage of the disease in comparison to the corresponding groups. No significant association of CYP1A1*2 polymorphism was observed with occupation, estrogen receptor and progesterone receptor status of breast cancer patients. CONCLUSIONS: In conclusion, our results suggest a significant correlation between CYP1A1*2 expression and the occurrence of breast cancer.en_US
dc.description.affiliationDepartment of Genetics, Osmania University, Hyderabad, India.en_US
dc.identifier.citationSurekha D, Sailaja K, Rao DN, Padma T, Raghunadharao D, Vishnupriya S. Association of CYP1A1*2 polymorphisms with breast cancer risk: a case control study. Indian Journal of Medical Sciences. 2009 Jan; 63(1): 13-20en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/67183
dc.language.isoengen_US
dc.source.urihttps://www.indianjmedsci.orgen_US
dc.subject.meshBreast Neoplasms --genetics
dc.subject.meshCase-Control Studies
dc.subject.meshCytochrome P-450 CYP1A2 --genetics
dc.subject.meshFemale
dc.subject.meshGenetic Predisposition to Disease
dc.subject.meshGenotype
dc.subject.meshHumans
dc.subject.meshPolymorphism, Genetic
dc.subject.meshReceptors, Estrogen --genetics
dc.subject.meshReceptors, Progesterone --genetics
dc.subject.meshRisk Assessment
dc.titleAssociation of CYP1A1*2 polymorphisms with breast cancer risk: a case control study.en_US
dc.typeJournal Articleen_US
dc.typeResearch Support, Non-U.S. Gov'ten_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Indian Journal of Medical Sciences